Development of α-Tocopherol Acetate Nanoparticles: Influence of Preparative Processes

We studied different methods of preparing α-tocopherol acetate (ATA) nanoparticles, which are to be used in targeting the lungs as aerosols in order to prevent cigarette smoke toxicity. Poly-(lactide) nanoparticles were prepared using nanoprecipitation and solvent evaporation techniques, which produced, respectively, too small and too large nanoparticles to be aerosolized. The emulsification-diffusion method produced 2 months stable nanoparticles with a size between (500–700 nm). Increasing ATA concentration (1–7 mg/mL) induced a decrease in the association rate (97–93%) and in the adsorbed ATA rate (7–4.5%), which was associated with variations of Zeta potentials (−27.5 to −24.3 mV) and decrease in polymeric wall thickness and density.

[1]  S. Antimisiaris,et al.  Liposomes for drug delivery to the lungs by nebulization. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  V. Castranova,et al.  Vitamin E deficiency enhances pulmonary inflammatory response and oxidative stress induced by single-walled carbon nanotubes in C57BL/6 mice. , 2007, Toxicology and applied pharmacology.

[3]  P. Rouxhet,et al.  Aerosolization properties, surface composition and physical state of spray-dried protein powders. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[4]  J. Hanes,et al.  Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[5]  E. Perrier,et al.  Synthesis and characterization of polyurethane and poly(ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification. , 2004, International journal of pharmaceutics.

[6]  W. Seeger,et al.  Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[7]  J. Hanes,et al.  New polymeric carriers for controlled drug delivery following inhalation or injection. , 2002, Biomaterials.

[8]  A. Orecchioni,et al.  α-Tocopherol encapsulation and in vitro release from wheat gliadin nanoparticles , 2002, Journal of microencapsulation.

[9]  K. Panda,et al.  Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis. , 1999, Free radical biology & medicine.

[10]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[11]  P. Couvreur,et al.  On shelf stability of freeze-dried poly(methylidene malonate 2.1.2) nanoparticles , 1997 .

[12]  Hatem Fessi,et al.  Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique , 1996 .

[13]  G. Atlan,et al.  Pulmonary clearance and lung function: influence of acute tobacco intoxication and of vitamin E. , 1996, Journal of applied physiology.

[14]  O.N.M. Mc Callion,et al.  Nebulisation of monodisperse latex sphere suspensions in air-jet and ultrasonic nebulisers , 1996 .

[15]  P. Shek,et al.  Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. , 1995, Biomedical and environmental sciences : BES.

[16]  J. Benoit,et al.  In vitro study of the anti-leishmanial activity of biodegradable nanoparticles. , 1995, Journal of drug targeting.

[17]  P. Shek,et al.  Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes. , 1995, Journal of drug targeting.

[18]  A. Taburet,et al.  Pharmacokinetic Optimisation of Asthma Treatment , 1994, Clinical pharmacokinetics.

[19]  M. Davies,et al.  The preparation of sub-200 nm biodegradable colloidal particles from poly(β-malic acid-co-benzyl malate) copolymers and their surface modification with Poloxamer and Poloxamine surfactants , 1994 .

[20]  P. Shek,et al.  Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. , 1994, Journal of drug targeting.

[21]  H. Schreier,et al.  Pulmonary delivery of liposomes , 1993 .

[22]  M. Nakakura,et al.  Blood clearance and tissue distribution of various formulations of alpha-tocopherol injection after intravenous administration. , 1993, Chemical & pharmaceutical bulletin.

[23]  K. Fukuzawa,et al.  Location, Antioxidant and Recycling Dynamics of α -Tocopherol in Liposome Membranes , 1993 .

[24]  P. Shek,et al.  Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity. , 1992, Biochemical pharmacology.

[25]  P. Wollmer,et al.  Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. , 1992, Thorax.

[26]  R. Jalil,et al.  Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties. , 1990, Journal of microencapsulation.

[27]  C. Johnson Principles of nebulizer-delivered drug therapy for asthma. , 1989, American journal of hospital pharmacy.

[28]  D. Cornwell,et al.  Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity. , 1986, The Journal of clinical investigation.

[29]  C. Chow,et al.  Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoking. , 1984, Environmental research.

[30]  M. Newhouse UFFI dust: nonspecific irritant only? , 1982, Chest.

[31]  B. E. Walker,et al.  INTAKE AND ABSORPTION OF TOCOPHEROL * , 1972, Annals of the New York Academy of Sciences.